Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/11000/35375
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorFemenía Cantó, Teresa-
dc.contributor.authorGómez Galán, Marta-
dc.contributor.authorLindskog, Maria-
dc.contributor.authorMagara, Salvatore-
dc.contributor.otherDepartamentos de la UMH::Farmacología, Pediatría y Química Orgánicaes_ES
dc.date.accessioned2025-01-28T12:02:32Z-
dc.date.available2025-01-28T12:02:32Z-
dc.identifier.citationBrain ResearchVolume, 2012;1476: 58-70es_ES
dc.identifier.issn1872-6240-
dc.identifier.issn0006-8993-
dc.identifier.urihttps://hdl.handle.net/11000/35375-
dc.description.abstractMood disorders, such as major depressive disorder (MDD), bipolar disorder and generalized anxiety disorder usually comprise mood related as well as cognitive symptoms and the interaction between these symptoms is still not clear. Most antidepressant drugs have a positive effect on mood but do not treat the cognitive dysfunctions or even aggravate the symptoms. In this review we will evaluate the association between mood and cognition in the context of mood disorders. In the first section we will summarize the brain circuits at the intersection between cognition and emotion, highlighting the role of the hippocampus. In the second section, we will survey the contribution of the glutamate and GABA systems in the pathophysiology of mood disorders, making an effort to understand the link between emotions and cognition and how novel therapeutic approaches deal with them. In the third section we will explore the monoamine involvement in the emotion/cognition duality in the context of mood disorders. Finally we will underline the role of synaptic plasticity and neurogenesis in depression. We consider that a broader knowledge about the integrative mechanisms involved in specific aspects of mood disorders is crucial in the development of more powerful and effective antidepressant drugs.es_ES
dc.formatapplication/pdfes_ES
dc.format.extent13es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsinfo:eu-repo/semantics/closedAccesses_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectMajor depressive disorderes_ES
dc.subjectStresses_ES
dc.subjectAmygdalaes_ES
dc.subjectHPAes_ES
dc.subjectPrefrontal cortexes_ES
dc.subjectGlutamatees_ES
dc.subjectGABAes_ES
dc.subjectDopaminees_ES
dc.subject.otherCDU::6 - Ciencias aplicadas::61 - Medicina::615 - Farmacología. Terapéutica. Toxicología. Radiologíaes_ES
dc.titleDysfunctional hippocampal activity affects emotion and cognition in mood disorderses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherversion10.1016/j.brainres.2012.03.053es_ES
Aparece en las colecciones:
Artículos Farmacología, Pediatría y Química Orgánica


no-thumbnailVer/Abrir:

 Dysfunctional hippocampal activity affects emotion and cognition in mood disorders.pdf



857,18 kB
Adobe PDF
Compartir:


Creative Commons La licencia se describe como: Atribución-NonComercial-NoDerivada 4.0 Internacional.